Angioimmunoblastic T cell lymphoma
Angioimmunoblastic T-cell lymphoma (AITL) is a rare, aggressive (fast-growing) form of peripheral T-cell lymphoma. It only accounts for around 1-2% of all non-Hodgkin lymphoma. It is one of the more common subtypes of mature T-cell lymphomas.
Epidemiology
It can be more common in the elderly.
Clinical presentation
The clinical spectrum includes high fevers, generalized lymphadenopathy, a skin rash, and hepatosplenomegaly.
Treatment and prognosis
Despite advances in treatment regimens for AITL, prognosis remains poor with an overall 5-year median survival of 32%. 3
Related Radiopaedia articles
Lymphoma
- overview of lymphoma
- WHO classification of tumors of hematopoietic and lymphoid tissues
- location-specific lymphomas
- central nervous system
- head and neck lymphoma
- thoracic lymphoma
- gastrointestinal lymphoma
- hepatobiliary lymphoma
- genitourinary lymphoma
- musculoskeletal lymphoma
- cutaneous lymphoma
- multi-regional
- lymphoma staging
Unable to process the form. Check for errors and try again.